- call +1-201-465-4211
- email sales@mrinsights.biz
Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
Scope of the Report:
This report studies the Pituitary cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pituitary cancer market by product type and applications/end industries.
While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.
The global Pituitary cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pituitary cancer.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Trinity Biotech
Salzman
Genentech
Sigma-Aldrich
Varian Medical Systems
Elekta
Accuray Incorporated
Ion Beam Applications
Nordion
C. R. Bard
Isoray Medical
RaySearch Laboratories
Mevion Medical Systems
Mitsubishi Electric
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Blood Tests
Urine Test
Brain Imaging
Vision Testing
Market Segment by Applications, can be divided into
Hospital
Clinics
Diagnostic Centers
Research Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Pituitary cancer Market Overview
1.1 Product Overview and Scope of Pituitary cancer
1.2 Classification of Pituitary cancer by Types
1.2.1 Global Pituitary cancer Revenue Comparison by Types (2017-2023)
1.2.2 Global Pituitary cancer Revenue Market Share by Types in 2017
1.2.3 Blood Tests
1.2.4 Urine Test
1.2.5 Brain Imaging
1.2.6 Vision Testing
1.3 Global Pituitary cancer Market by Application
1.3.1 Global Pituitary cancer Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Research Institutes
1.4 Global Pituitary cancer Market by Regions
1.4.1 Global Pituitary cancer Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Pituitary cancer Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Pituitary cancer Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pituitary cancer Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Pituitary cancer Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pituitary cancer Status and Prospect (2013-2023)
1.5 Global Market Size of Pituitary cancer (2013-2023)
2 Manufacturers Profiles
2.1 Trinity Biotech
2.1.1 Business Overview
2.1.2 Pituitary cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Trinity Biotech Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.2 Salzman
2.2.1 Business Overview
2.2.2 Pituitary cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Salzman Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.3 Genentech
2.3.1 Business Overview
2.3.2 Pituitary cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Genentech Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sigma-Aldrich
2.4.1 Business Overview
2.4.2 Pituitary cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sigma-Aldrich Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.5 Varian Medical Systems
2.5.1 Business Overview
2.5.2 Pituitary cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Varian Medical Systems Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.6 Elekta
2.6.1 Business Overview
2.6.2 Pituitary cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Elekta Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.7 Accuray Incorporated
2.7.1 Business Overview
2.7.2 Pituitary cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Accuray Incorporated Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ion Beam Applications
2.8.1 Business Overview
2.8.2 Pituitary cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ion Beam Applications Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nordion
2.9.1 Business Overview
2.9.2 Pituitary cancer Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nordion Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.10 C. R. Bard
2.10.1 Business Overview
2.10.2 Pituitary cancer Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 C. R. Bard Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.11 Isoray Medical
2.11.1 Business Overview
2.11.2 Pituitary cancer Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Isoray Medical Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.12 RaySearch Laboratories
2.12.1 Business Overview
2.12.2 Pituitary cancer Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 RaySearch Laboratories Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.13 Mevion Medical Systems
2.13.1 Business Overview
2.13.2 Pituitary cancer Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Mevion Medical Systems Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
2.14 Mitsubishi Electric
2.14.1 Business Overview
2.14.2 Pituitary cancer Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Mitsubishi Electric Pituitary cancer Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pituitary cancer Market Competition, by Players
3.1 Global Pituitary cancer Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Pituitary cancer Players Market Share
3.2.2 Top 10 Pituitary cancer Players Market Share
3.3 Market Competition Trend
4 Global Pituitary cancer Market Size by Regions
4.1 Global Pituitary cancer Revenue and Market Share by Regions
4.2 North America Pituitary cancer Revenue and Growth Rate (2013-2018)
4.3 Europe Pituitary cancer Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Pituitary cancer Revenue and Growth Rate (2013-2018)
4.5 South America Pituitary cancer Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Pituitary cancer Revenue and Growth Rate (2013-2018)
5 North America Pituitary cancer Revenue by Countries
5.1 North America Pituitary cancer Revenue by Countries (2013-2018)
5.2 USA Pituitary cancer Revenue and Growth Rate (2013-2018)
5.3 Canada Pituitary cancer Revenue and Growth Rate (2013-2018)
5.4 Mexico Pituitary cancer Revenue and Growth Rate (2013-2018)
6 Europe Pituitary cancer Revenue by Countries
6.1 Europe Pituitary cancer Revenue by Countries (2013-2018)
6.2 Germany Pituitary cancer Revenue and Growth Rate (2013-2018)
6.3 UK Pituitary cancer Revenue and Growth Rate (2013-2018)
6.4 France Pituitary cancer Revenue and Growth Rate (2013-2018)
6.5 Russia Pituitary cancer Revenue and Growth Rate (2013-2018)
6.6 Italy Pituitary cancer Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Pituitary cancer Revenue by Countries
7.1 Asia-Pacific Pituitary cancer Revenue by Countries (2013-2018)
7.2 China Pituitary cancer Revenue and Growth Rate (2013-2018)
7.3 Japan Pituitary cancer Revenue and Growth Rate (2013-2018)
7.4 Korea Pituitary cancer Revenue and Growth Rate (2013-2018)
7.5 India Pituitary cancer Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Pituitary cancer Revenue and Growth Rate (2013-2018)
8 South America Pituitary cancer Revenue by Countries
8.1 South America Pituitary cancer Revenue by Countries (2013-2018)
8.2 Brazil Pituitary cancer Revenue and Growth Rate (2013-2018)
8.3 Argentina Pituitary cancer Revenue and Growth Rate (2013-2018)
8.4 Colombia Pituitary cancer Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Pituitary cancer by Countries
9.1 Middle East and Africa Pituitary cancer Revenue by Countries (2013-2018)
9.2 Saudi Arabia Pituitary cancer Revenue and Growth Rate (2013-2018)
9.3 UAE Pituitary cancer Revenue and Growth Rate (2013-2018)
9.4 Egypt Pituitary cancer Revenue and Growth Rate (2013-2018)
9.5 Nigeria Pituitary cancer Revenue and Growth Rate (2013-2018)
9.6 South Africa Pituitary cancer Revenue and Growth Rate (2013-2018)
10 Global Pituitary cancer Market Segment by Type
10.1 Global Pituitary cancer Revenue and Market Share by Type (2013-2018)
10.2 Global Pituitary cancer Market Forecast by Type (2018-2023)
10.3 Blood Tests Revenue Growth Rate (2013-2023)
10.4 Urine Test Revenue Growth Rate (2013-2023)
10.5 Brain Imaging Revenue Growth Rate (2013-2023)
10.6 Vision Testing Revenue Growth Rate (2013-2023)
11 Global Pituitary cancer Market Segment by Application
11.1 Global Pituitary cancer Revenue Market Share by Application (2013-2018)
11.2 Pituitary cancer Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
11.6 Research Institutes Revenue Growth (2013-2018)
12 Global Pituitary cancer Market Size Forecast (2018-2023)
12.1 Global Pituitary cancer Market Size Forecast (2018-2023)
12.2 Global Pituitary cancer Market Forecast by Regions (2018-2023)
12.3 North America Pituitary cancer Revenue Market Forecast (2018-2023)
12.4 Europe Pituitary cancer Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Pituitary cancer Revenue Market Forecast (2018-2023)
12.6 South America Pituitary cancer Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Pituitary cancer Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Pituitary cancer Picture
Table Product Specifications of Pituitary cancer
Table Global Pituitary cancer and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
